EEG Biomarkers for OUD: Diagnostic, Prognostic, and Predictive Applications
A legfontosabb adatok
- Ki végzi
- University of Illinois Chicago
- Hol
- Cambridge, Chicago és Pomona (Egyesült Államok)Mind a 3 helyszín megnézése
- Azonosító
- Állapot
- Fut, nem toboroz
- Résztvevők
- 70 fő, tervezett
- Kezdés
- 2025. febr. 4.
- Várható befejezés
- 2027. szept. 15.
- A vizsgálat típusa
- Megfigyeléses, 2 csoport
- A regiszteradat frissítve
- 2026. október 13.
Ki vehet részt
- Életkor
- 22 év – 85 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Részt vehetnek
A regiszter feltételei, szó szerint
Mind a 14 feltétel megnézéseKevesebb
Ki vehet részt
- For OUD Subjects:; Providing informed consent to participate in the study; 22 to 85 years old; Having a diagnosis of OUD
- OUD of more than 6 months duration as defined by Diagnostic and Statistical Manual of Mental Disorders (DSM-5) [71] with a positive urine toxicology screen who still feel craving
- Lives in immediate area with no plans to relocate; For age-matched controls:
- Providing informed consent to participate in the study
- 22 to 85 years old
- Lives in immediate area with no plans to relocate
Ki nem vehet részt
- Recently started on antiepileptic drug therapy
- History of neurological disorders involving stroke, brain tumors, or epilepsy as self- reported
- History of unexplained fainting spells as self-reported
- History of head injury resulting in more than a momentary loss of consciousness as self-reported
- History of brain surgery as self-reported
- Active malignancy
- For OUD Subjects:; Recently started on antiepileptic drug therapy; Ingestion of poppy seeds or herbal teas containing Papaveris fructus (may cause a positive opiate test for morphine, codeine [72,73]); History of neurological disorders involving stroke, brain tumors, or epilepsy as self- reported; History of unexplained fainting spells as self-reported; History of head injury resulting in more than a momentary loss of consciousness as self-reported; History of brain surgery as self-reported; Suffering from severe depression; Active malignancy; For age-matched controls:
- Suffering from severe depression
Helyszínek itt: Egyesült Államok
- Spaulding Rehabilitation Hospital - 5th Floor - Neuromodulation CenterCambridge, Egyesült Államok
- Clinical & Imaging Research Outcomes LabChicago, Egyesült Államok
- Casa Colina Hospital and Centers for HealthcarePomona, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
The US is suffering from a national opioid epidemic characterized by significant costs, overdoses, and deaths. Conventional Opioid Use Disorder (OUD) treatments (i.e., pharmacological and psychosocial interventions) are characterized by limited or diminishing efficacy, ceiling effects, and/or serious side effects. The availability of validated OUD biomarkers would be a key step in the development and approval of better treatments. Ultimately, the scarcity of OUD biomarkers represents a significant unmet need in the fight against opioid addiction as recognized by NIDA and the FDA with their support for development of Medical Device Development Tools (MDDT) and biomarker tests for OUD. Advances in neuroimaging techniques, and in particular recent evidence supports electroencephalography (EEG) as a promising candidate to investigate the correlation between addiction and brain state. To address the clear medical and market need for OUD biomarkers, this is a feasibility study to identify and assess potential EEG biomarkers for OUD diagnoses, disease monitoring, and prediction of OUD treatment response.
A vizsgálat 2 csoportja
- Opioid Use Disorder
Diagnosed Opioid Use Disorder subjects will perform 2 EEG sessions done at the initial visit and one week later. EEG recordings will be taken to monitor brain activity
- Healthy Control
Age-matched healthy controls. Subjects will perform 2 EEG sessions done at the initial visit and one week later. EEG recordings will be taken to monitor brain activity
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Developing EEG Biomarkers for OUD Diagnostic, Prognostic, and Predictive Purposes
- A regiszteradat frissítve
- 2026. október 13.